1. Home
  2. WIA vs ARCT Comparison

WIA vs ARCT Comparison

Compare WIA & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Income Fund

WIA

Western Asset Inflation-Linked Income Fund

N/A

Current Price

$8.24

Market Cap

197.8M

Sector

Finance

ML Signal

N/A

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

N/A

Current Price

$6.56

Market Cap

194.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WIA
ARCT
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.8M
194.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WIA
ARCT
Price
$8.24
$6.56
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$38.67
AVG Volume (30 Days)
39.2K
846.7K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
12.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$97,601,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.56
$5.85
52 Week High
$8.91
$24.17

Technical Indicators

Market Signals
Indicator
WIA
ARCT
Relative Strength Index (RSI) 36.66 35.29
Support Level $8.19 $7.04
Resistance Level $8.29 $7.76
Average True Range (ATR) 0.06 0.42
MACD -0.00 0.30
Stochastic Oscillator 16.67 26.65

Price Performance

Historical Comparison
WIA
ARCT

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: